Literature DB >> 181899

The parvoviruses.

G Siegl.   

Abstract

Mesh：

Substances：

Year:  1976        PMID： 181899

Source DB:  PubMed          Journal:  Virol Monogr        ISSN： 0083-6591


× No keyword cloud information.
  7 in total

1.  The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts.

Authors:  Justin Paglino; Peter Tattersall
Journal:  Virology       Date:  2011-05-20       Impact factor: 3.616

2.  Restriction map of the single-stranded DNA genome of Kilham rat virus strains 171, a nondefective parvovirus.

Authors:  P T Banerjee; R Rothrock; S Mitra
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

3.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Intracellular DNA of the parvovirus minute virus of mice is organized in a minichromosome structure.

Authors:  E Ben-Asher; S Bratosin; Y Aloni
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

5.  Transcription of minute virus of mice, an autonomous parvovirus, may be regulated by attenuation.

Authors:  E Ben-Asher; Y Aloni
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

6.  Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice.

Authors:  J J Cornelis; P Becquart; N Duponchel; N Salomé; B L Avalosse; M Namba; J Rommelaere
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro.

Authors:  N Young; M Harrison; J Moore; P Mortimer; R K Humphries
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.